Globus Medical (GMED) Short-term Investments (2013 - 2026)

Globus Medical (GMED) has reported Short-term Investments for 14 consecutive years, with $87.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short-term Investments changed N/A year-over-year to $87.4 million; the trailing twelve-month figure through Jun 2026 stood at $87.4 million (changed N/A YoY), and the FY2025 full-year result was $31.1 million, down 70.57% from the prior year.
• Short-term Investments improved to $87.4 million in Q2 2026 per GMED's latest filing, from $68.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $306.4 million in Q2 2023 and bottomed at $18.8 million in Q3 2025.
• Historically, Short-term Investments has averaged $152.9 million across 5 years, with a median of $96.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments slumped 82.92% in 2023, then surged 109.16% in 2024.
• Over 5 years, Short-term Investments stood at $295.6 million in 2022, then plunged by 82.92% to $50.5 million in 2023, then soared by 109.16% to $105.6 million in 2024, then slumped by 70.57% to $31.1 million in 2025, then soared by 181.14% to $87.4 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $87.4 million, $68.9 million, and $31.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.